Evidence map›Paper›PMID 41943999›Full record

ReviewDalton transactions (Cambridge, England : 2003)2026

Solid-state molecular organometallic chemistry (SMOM): a user guide to

Kristof M Altus, Samantha K Furfari, Joe C Goodall, Matthew R Gyton, Jack H Heaton, Chloe L Johnson, Alasdair I McKay, Mads Sondrup Møller, Sebastian D Pike, Andrew S Weller

Abstract readReview
In one paragraph

Review in Dalton transactions (Cambridge, England : 2003), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kristof M AltusDepartment of Chemistry, University of York, Heslington, York, YO10 5DD, UK. andrew.weller@york.ac.uk.ORCID http://orcid.org/0000-0002-8072-8346
Samantha K FurfariSchool of Chemistry, University of New South Wales, Sydney, NSW 2052, Australia.ORCID http://orcid.org/0000-0001-6131-0529
Joe C GoodallDepartment of Chemistry, University of York, Heslington, York, YO10 5DD, UK. andrew.weller@york.ac.uk.ORCID http://orcid.org/0000-0002-7582-8713
Matthew R GytonSchool of Science, University of Wollongong, Wollongong, NSW 2522, Australia.ORCID http://orcid.org/0000-0002-7565-5154
Jack H HeatonDepartment of Chemistry, University of York, Heslington, York, YO10 5DD, UK. andrew.weller@york.ac.uk.ORCID http://orcid.org/0009-0008-4033-5194
Chloe L JohnsonDepartment of Chemistry, University of York, Heslington, York, YO10 5DD, UK. andrew.weller@york.ac.uk.ORCID http://orcid.org/0000-0002-0183-2955
Alasdair I McKaySchool of Chemistry, Monash University, Melbourne, Victoria 3800, Australia.ORCID http://orcid.org/0000-0002-6859-172X
Mads Sondrup MøllerDepartment of Chemistry, University of York, Heslington, York, YO10 5DD, UK. andrew.weller@york.ac.uk.ORCID http://orcid.org/0000-0003-1674-7742
Sebastian D PikeDepartment of Chemistry, University of Warwick, Coventry, CV4 7AL, UK.ORCID http://orcid.org/0000-0002-9791-5244
Andrew S WellerDepartment of Chemistry, University of York, Heslington, York, YO10 5DD, UK. andrew.weller@york.ac.uk.ORCID http://orcid.org/0000-0003-1646-8081

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41943999
PMCPMC13586595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.